Abstract:Background: Acute ischemic stroke is a leading cause of mortality and disability in the US, with 50% of patients with minor stroke symptoms (MSS). Large vessel occlusion (LVO) is found in 10% of MSS cases and predicts poor neurological outcomes. However, treatment strategies for MSS-LVO lack consensus, and a deeper understanding of the natural history of MSS-LVO is needed. Methods: We screened all patients presenting to a large stroke network, from May 2017 to August 2023, for intracranial anterior circulation LVO and MSS (NIHSS %lt 6). Descriptive statistics were applied to demographic, clinical, radiographic, and neurological outcomes data, including early neurological deterioration (END) (NIHSS gain 3+). Results: Ninety patients participated in the study, averaging 64.5 years old, with 58.8% male, 48.8% white, 22.2% black, and 16.2% Hispanic. Comorbidities included diabetes (23%), hypertension (67.7%), atrial fibrillation (22%), hyperlipidemia (53%), and smoking (40%). Patients arrived with mean 7 hours (SE 1.6) from LKW, and a mean NIHSS 3.95 (SE 0.40). The majority of patients had baseline mRS of 0-2 (92.6%). Occlusion sites included M1 (38.9%), M2 (40%), and ICA terminus (2.2%). The mean ASPECTS score was 9.4 (SE 0.13). Immediate thrombolytic treatment was delivered to 34% of patients. Out of 90 patients, 31 (34%) suffered END, with mean NIHSS at END of 9.17 (SE 0.85), necessitating rescue endovascular thrombectomy (EVT). Collateral vessel failure caused 87.1% of END cases, clot migration 9.7%, and additional strokes 3.2%. Of the 31 EVT cases, 29 (93%) achieved TICI 2b-3, averaging 3.1 (SE 0.35) passes. ICH occurred in 5 patients; 2 had undergone EVT, although none were symptomatic. At 24 hours and 5 days from presentation, the mean NIHSS were 3.15 and 2.86 respectively, worse in END patients (6.16 vs 1.55, p=0.00, and 6.28 vs 1.14, p=0.00). After 30 days, only 66% of END patients had mRS of 0-2 compared to 84% of non-END patients (p=0.02). Similarly, at 90 days, only 65% of END patients, versus 86% of non-END patients, had mRS of 0-2 (p=0.02). Conclusion: The study details the natural history of MSS-LVO, showing a prominent incidence of EVT-requiring END due to collateral failure. Future research should identify high-risk END patients for tailored treatment.

Large-Vessel Occlusion is Associated with Poor Outcome in Stroke Patients Aged 80 Years or Older Who Underwent Intravenous Thrombolysis.

Characteristics and Outcomes of Intravenous Thrombolysis in Mild Ischemic Stroke Patients

Does Large Vessel Occlusion Affect Clinical Outcome in Stroke with Mild Neurologic Deficits after Intravenous Thrombolysis?

Exploring the Relationship Between Ischemic Core Volume and Clinical Outcomes after Thrombectomy or Thrombolysis

[Factors Related to Therapeutic Outcomes of Intravenous Thrombolysis in Stroke Patients with Different Severity].

Maximal Infarct Volume to Benefit from Intravenous Thrombolysis and Its Relation with Onset to Treatment Time

Too Good to Treat? Ischemic Stroke Patients with Small Computed Tomography Perfusion Lesions May Not Benefit from Thrombolysis

Association Between Leukoaraiosis and Poor Outcome is Not Due to Reperfusion Inefficiency after Intravenous Thrombolysis

Different Risk Factors for Poor Outcome Between Patients with Positive and Negative Susceptibility Vessel Sign

Predictors of favorable functional outcomes for elderly patients undergoing endovascular thrombectomy for acute ischemic stroke

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Vascular Risk Factors In Patients With Different Subtypes Of Ischemic Stroke May Affect Their Outcome After Intravenous Tpa

Abstract TP149: Pretreatment Parameters Predicting Excellent Recanalization of Large Vessel Occlusion in Patients With Acute Ischemic Stroke

Abstract TP82: Effect of Stroke Etiology and Treatment Intervention for Young Adults With Large Vessel Occlusion- Acute Ischemic Stroke: Results From the Cleveland Clinic Young Adult Retrospective Cohort Study

Efficacy and Outcome Predictors of Intravenous Thrombolysis for Patients with Acute Ischemic Stroke

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke

Specific Factors to Predict Large-Vessel Occlusion in Acute Stroke Patients

Abstract WP2: Natural History of Large Vessel Occlusion Patients Presenting With Minor Stroke Symptoms

Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment.

Abstract 86: Outcomes of Endovascular Therapy for Late Large Vessel Occlusion in Patients With Pre-Stroke Disability

Abstract WMP5: Intravenous Thrombolysis Before Thrombectomy Improves Functional Outcome After Stroke Independent of Reperfusion Grade